InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II.

By H. Marrakchi, G. Lanéelle, A. Quémard. 2000

248 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Molecular Medicine, Computational Biology & Bioinformatics

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Maria Batool
2. Sangdun Choi
3. Bilal Ahmad

In Infectious Diseases

1. Maria Batool
2. Sangdun Choi
3. Bilal Ahmad

In Molecular Medicine

1. Maria Batool
2. Sangdun Choi
3. Bilal Ahmad

In Computational Biology & Bioinformatics

1. Maria Batool
2. Sangdun Choi
3. Bilal Ahmad

Citations in the corpus

• A Structure-Based Drug Discovery Paradigm (2019, methodology): “Isoniazid InhA Tuberculosis Structure-based virtual screening (SBVS) and pharmacophore modeling [22]”
• Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis (2005, background): “smegmatis displays long-chain fatty acid elongation activity, which promotes the elongation of C16-ACP to form C18- to C30-ACP products (59).”